Costi di malattia: revisione degli studi europei e nordamericani

Part of the Aspetti psico-sociali della sclerosi multipla book series (APSSM, volume 4)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Grudzinski AN, Hakim Z, Cox ER, Bootman JL (1999) The economics of multiple sclerosis. Distribution of costs and relationship to disease severity. Pharmacoeconomics 15(3):229–240PubMedGoogle Scholar
  2. 2.
    Henriksson F, Jonsson B (1998) The economic cost of multiple sclerosis in Sweden in 1994. Pharmacoeconomics 13:597–606Google Scholar
  3. 3.
    Holmes BA, Madgkick T, Bates D (1995) The cost of MS. Br J Med Econ 8:181–193Google Scholar
  4. 4.
    Blumhardt L, Wood C (1996) The economics of multiple sclerosis: a cost of illness study. Br J Med Econ 10:99–118Google Scholar
  5. 5.
    Carton H, Loos R, Pacolet J et al (1998) Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium). J Neurol Neurosurg Psychiatry 64(4):444–450PubMedGoogle Scholar
  6. 6.
    Murphy N, Confavreux C, Haas J et al (1998) Economic evaluation of multiple sclerosis in the UK, Germany and France. Pharmacoeconomics 13:607–622Google Scholar
  7. 7.
    Amato MP, Battaglia MA, Caputo D et al for the Mu. S. I. C. Study Group (2002) The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy. J Neurol 249(2):152–163PubMedGoogle Scholar
  8. 8.
    Russo P, Capone A, Paolilo A et al (2004) Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of the new disease-modifying agents. Clin Drug Invest 24(7):421–432Google Scholar
  9. 9.
    Inman RP (1984) Disability indices, the economic costs of illness and social insurance: the cost of MS. Acta Neurol Scand 101:46–55Google Scholar
  10. 10.
    Bourdette DN, Prochazka AV, Mitchell W et al (1993) Health care costs of veterans with multiple sclerosis: implications for the rehabilitation of MS. VA Multiple Sclerosis Rehabilitation Study Group. Arch Phys Med Rehab 74(1):26–31Google Scholar
  11. 11.
    Whetten-Goldstein K, Sloan FA, Goldstein LB, Kulas ED (1998) A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler 4(5):419–425PubMedCrossRefGoogle Scholar
  12. 12.
    Pope GC, Urato CJ, Kulas ED et al (2002) Prevalence, expenditures, utilization, and payment for persons with MS in insured populations. Neurology 58(1):37–43PubMedGoogle Scholar
  13. 13.
    Asche CV, Ho E, Chan B, Coyte PC (1997) Economic consequences of multiple sclerosis for Canadians. Acta Neurol Scand 95(5):268–274PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2005

Authors and Affiliations

There are no affiliations available

Personalised recommendations